Norges Bank Nektar Therapeutics Transaction History

Norges Bank

$716 Trillion
Q3 2024

46 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2024	BUY	$0.51 - $1.05 $133,348 - $274,541	261,468 New	261,468 $156,000
Q3 2023 Nov 13, 2023	SELL	$0.51 - $1.05 $865,394 - $1.78 Million	-1,696,851 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$0.53 - $1.03 $138,578 - $269,312	261,468 New	261,468 $151,000
Q2 2023 Aug 14, 2023	SELL	$0.53 - $1.03 $899,331 - $1.75 Million	-1,696,851 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$0.64 - $3.15 $167,339 - $823,624	261,468 New	261,468 $183,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $4.28 $3.44 Million - $7.26 Million	1,696,851 New	1,696,851 $3.83 Million
Q3 2022 Nov 13, 2023	BUY	$3.04 - $5.14 $5.16 Million - $8.72 Million	1,696,851 New	1,696,851 $5.43 Million
Q2 2022 Aug 14, 2023	BUY	$3.17 - $6.17 $5.38 Million - $10.5 Million	1,696,851 New	1,696,851 $6.45 Million
Q1 2022 May 12, 2023	SELL	$4.16 - $13.72 $421,104 - $1.39 Million	-101,227 Reduced 5.97%	1,595,624 $8.6 Million
Q1 2022 May 09, 2022	SELL	$4.16 - $13.72 $7.35 Million - $24.2 Million	-1,767,420 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$10.83 - $18.41 $19.1 Million - $32.5 Million	1,767,420 New	1,767,420 $23.9 Million
Q3 2021 Nov 14, 2022	BUY	$13.07 - $18.84 $18.7 Million - $27 Million	1,431,820 New	1,431,820 $25.7 Million
Q3 2021 Nov 05, 2021	SELL	$13.07 - $18.84 $23.7 Million - $34.1 Million	-1,812,494 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$16.52 - $20.4 $29.9 Million - $37 Million	1,812,494 New	1,812,494 $31.1 Million
Q2 2021 Aug 10, 2021	SELL	$16.52 - $20.4 $30.6 Million - $37.8 Million	-1,854,692 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$16.56 - $25.46 $30.7 Million - $47.2 Million	1,854,692 New	1,854,692 $37.1 Million
Q1 2021 May 07, 2021	SELL	$16.56 - $25.46 $36.3 Million - $55.8 Million	-2,191,199 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$15.77 - $19.03 $34.6 Million - $41.7 Million	2,191,199 New	2,191,199 $37.3 Million
Q4 2020 Feb 10, 2021	SELL	$15.77 - $19.03 $34.6 Million - $41.7 Million	-2,191,199 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$16.59 - $24.79 $36.4 Million - $54.3 Million	2,191,199 New	2,191,199 $36.4 Million
Q3 2020 Nov 10, 2020	SELL	$16.59 - $24.79 $38.9 Million - $58.2 Million	-2,345,993 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$16.86 - $23.44 $39.6 Million - $55 Million	2,345,993 New	2,345,993 $54.3 Million
Q2 2020 Aug 07, 2020	SELL	$16.86 - $23.44 $41 Million - $57 Million	-2,432,006 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$14.47 - $27.96 $35.2 Million - $68 Million	2,432,006 New	2,432,006 $43.4 Million
Q1 2020 May 08, 2020	SELL	$14.47 - $27.96 $35.2 Million - $68 Million	-2,432,006 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$15.87 - $23.12 $38.6 Million - $56.2 Million	2,432,006 New	2,432,006 $52.5 Million
Q4 2019 Feb 12, 2020	SELL	$15.87 - $23.12 $39.4 Million - $57.4 Million	-2,482,501 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$16.91 - $36.27 $42 Million - $90 Million	2,482,501 New	2,482,501 $45.2 Million
Q3 2019 Nov 08, 2019	SELL	$16.91 - $36.27 $38.6 Million - $82.7 Million	-2,280,364 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$31.0 - $36.3 $70.7 Million - $82.8 Million	2,280,364 New	2,280,364 $81.1 Million
Q2 2019 Aug 09, 2019	SELL	$31.0 - $36.3 $60.1 Million - $70.4 Million	-1,938,621 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$30.43 - $56.65 $59 Million - $110 Million	1,938,621 New	1,938,621 $63.7 Million
Q4 2018 Feb 08, 2019	SELL	$30.43 - $56.65 $52 Million - $96.8 Million	-1,708,067 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$46.46 - $68.49 $79.4 Million - $117 Million	1,708,067 New	1,708,067 $104 Million
Q3 2018 Nov 09, 2018	SELL	$46.46 - $68.49 $76.3 Million - $113 Million	-1,643,219 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$46.25 - $104.45 $76 Million - $172 Million	1,643,219 New	1,643,219 $80.2 Million
Q2 2018 Jul 23, 2018	SELL	$46.25 - $104.45 $65 Million - $147 Million	-1,405,805 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$57.4 - $108.44 $80.7 Million - $152 Million	1,405,805 New	1,405,805 $149 Million
Q1 2018 May 09, 2018	SELL	$57.4 - $108.44 $139 Million - $263 Million	-2,424,789 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$23.02 - $60.5 $55.8 Million - $147 Million	2,424,789 New	2,424,789 $145 Million
Q4 2017 Feb 09, 2018	SELL	$23.02 - $60.5 $62.5 Million - $164 Million	-2,713,717 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$17.79 - $24.0 $48.3 Million - $65.1 Million	2,713,717 New	2,713,717 $65.1 Million
Q3 2017 Nov 07, 2017	SELL	$17.79 - $24.0 $48.3 Million - $65.1 Million	-2,713,717 Closed	0 $0
Q2 2017 Jul 24, 2018	BUY	N/A	361,392 Added 15.36%	2,713,717 $53.1 Million
Q1 2017 May 11, 2018	BUY	N/A	50,616 Added 2.2%	2,352,325 $55.2 Million
Q3 2016 Nov 13, 2017	BUY	N/A	2,301,709	2,301,709 $0

Others Institutions Holding NKTR

# of Institutions

147

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$17 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$16.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$14 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$10.1 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.84 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account